Keywords: Amgen, Financial results, Third-quarter 2012

Amgen's third quarter 2012 sales and earnings top analysts' expectations

Article | 24 October 2012

Print This

The world’s largest biotech company, USA-based Amgen (Nasdaq: AMGN), posted financial results for the third quarter of 2012, showing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in